GlassScriptPhysician profile
Ashka D Patel
NPI 1588348429
$4,706.70
in general payments reported to CMS, 2019-2025
13 companies · $3,298 in 2025
The $3,298 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $431 · 2024: $978 · 2025: $3,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742 · Travel and Lodging: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,741.69 |
| Travel and Lodging | $965.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,594.35 | 2024-2025 | Acuvue |
| Alcon Vision LLC | $638.76 | 2024-2025 | Rocklatan, Precision7, Dailies Total1 |
| Bausch & Lomb Americas INC. | $508.13 | 2023-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $480.91 | 2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Harrow Eye, LLC | $325.79 | 2024-2025 | Vevye |
| Visioneering Technologies, INC. | $251.43 | 2025 | |
| Sun Pharmaceutical Industries INC. | $224.45 | 2023-2024 | Cequa |
| Glaukos Corporation | $193.73 | 2024-2025 | Photrexa Viscous and Photrexa, Radius, Ce-Marked Kxla System |
| Oyster Point Pharma, INC. | $191.72 | 2023-2024 | Tyrvaya |
| Dompe US, INC. | $111.25 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $84.29 | 2025 | Xdemvy |
| Abbvie INC. | $81.87 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $20.02 | 2024 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashka Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.